Title:
ANTI-β-NGF NANOBODY AND USE THEREFOR
Document Type and Number:
WIPO Patent Application WO/2020/248942
Kind Code:
A1
Abstract:
Provided is a nanobody or a polyvalent nanobody bound with a β-NGF antigen that may be used to treat, prevent, detect, or diagnose conditions related to β-NGF, such as pain or inflammation, and particularly used for pain after surgery, pain from rheumatoid arthritis, and pain from osteoarthritis.
Inventors:
LIU HONG (CN)
SONG DEYONG (CN)
XING PINGPING (CN)
SONG DEYONG (CN)
XING PINGPING (CN)
Application Number:
PCT/CN2020/094938
Publication Date:
December 17, 2020
Filing Date:
June 08, 2020
Export Citation:
Assignee:
SHANDONG BOAN BIOTECHNOLOGY CO LTD (CN)
International Classes:
A61K39/395; C07K16/22; A61P19/02; A61P25/00; C12N15/13
Domestic Patent References:
WO2012075340A2 | 2012-06-07 | |||
WO2013184871A1 | 2013-12-12 | |||
WO2004058184A2 | 2004-07-15 | |||
WO2011049758A1 | 2011-04-28 | |||
WO2010128398A1 | 2010-11-11 | |||
WO2009023540A1 | 2009-02-19 |
Download PDF:
Previous Patent: A FOOD PROCESSOR
Next Patent: NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC DEVICE
Next Patent: NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC DEVICE